Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, is restructuring in order to leverage its peptide platform by prioritizing investment in its research and development pipeline programs and streamline its commercial operations.   The changes will refocus the company’s resources reducing expenses while investing in strategic development and commercialization partnerships of pipeline assets. As a part of the process, Dr. A...